Diabetic Ketoacidosis as an Effect of Sodium-Glucose Cotransporter 2 Inhibitor: Real World Insights
One of the notable adverse effects of sodium-glucose cotransporter 2 (SGLT2) inhibitor is diabetic ketoacidosis (DKA) often characterized by euglycemia. In this retrospective review of patients with DKA from 2015 to 2023, 21 cases of SGLT2 inhibitorassociated DKA were identified. Twelve (57.1%) exhi...
Saved in:
| Main Authors: | Han-Sang Baek, Chaiho Jeong, Yeoree Yang, Joonyub Lee, Jeongmin Lee, Seung-Hwan Lee, Jae Hyoung Cho, Tae-Seo Sohn, Hyun-Shik Son, Kun-Ho Yoon, Eun Young Lee |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korean Diabetes Association
2024-11-01
|
| Series: | Diabetes & Metabolism Journal |
| Subjects: | |
| Online Access: | http://e-dmj.org/upload/pdf/dmj-2024-0036.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Euglycemic Diabetic Ketoacidosis in a Pregnant Patient on Insulin Pump Therapy
by: Hesham Yasin, MD, et al.
Published: (2025-01-01) -
Risk of diabetic ketoacidosis caused by sodium glucose cotransporter-2 inhibitors in patients with type 1 diabetes: a systematic review and network meta-analysis of randomized controlled trials
by: Ying Liu, et al.
Published: (2025-01-01) -
Evaluation of Children Presenting with Diabetic Ketoacidosis
by: Ekrem Koyuncu, et al.
Published: (2016-12-01) -
Diabetic ketoacidosis as a complication of immune checkpoint inhibitor therapy
by: Nathan L. Haas, et al.
Published: (2023-06-01) -
Severe hypertriglyceridemia in an adolescent female with diabetic ketoacidosis: A case report
by: Noopur N. Kulkarni, et al.
Published: (2024-09-01)